Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Breast Cancer Research and Treatment
|
December 1, 2005
Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk
Uwe Langsenlehner, Wilfried Renner, Babak Yazdani-Biuki, et al.
Breast Cancer Research and Treatment
|
January 2, 2004
The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer
Peter Krippl, Uwe Langsenlehner, Wilfried Renner, et al.
Wiener Klinische Wochenschrift
|
April 26, 2023
[Lipids-Diagnosis and therapy in diabetes mellitus (Update 2023)]
Thomas C Wascher, Bernhard Paulweber, Hermann Toplak, et al.
Wiener Klinische Wochenschrift
|
April 14, 2019
[Lipids-Diagnosis and therapy in diabetes mellitus (Update 2019)]
Thomas C Wascher, Bernhard Paulweber, Hermann Toplak, et al.
Wiener Klinische Wochenschrift
|
December 20, 2012
[Insulin therapy of diabetes]
Monika Lechleitner, Michael Roden, Raimund Weitgasser, et al.
Wiener Klinische Wochenschrift
|
April 26, 2023
[Obesity and type 2 diabetes (Update 2023)]
Martin Clodi, Hermann Toplak, Michael Resl, et al.
Wiener Klinische Wochenschrift
|
April 8, 2016
[Insulin therapy of diabetes]
Monika Lechleitner, Michael Roden, Raimund Weitgasser, et al.
Breast Cancer Research and Treatment
|
September 21, 2004
Genetic variants of the sulfotransferase 1A1 and breast cancer risk
Uwe Langsenlehner, Peter Krippl, Wilfried Renner, et al.
Angiology
|
July 24, 2009
The functional promoter polymorphism of the coagulation factor XII gene is not associated with peripheral arterial disease
Babak Yazdani-Biuki, Peter Krippl, Kerstin Brickmann, et al.
Breast Cancer Research and Treatment
|
July 20, 2007
Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study
Uwe Langsenlehner, Gerald Wolf, Tanja Langsenlehner, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Breast Cancer Research and Treatment
|
December 1, 2005
Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk
Uwe Langsenlehner, Wilfried Renner, Babak Yazdani-Biuki, et al.
Breast Cancer Research and Treatment
|
January 2, 2004
The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer
Peter Krippl, Uwe Langsenlehner, Wilfried Renner, et al.
Wiener Klinische Wochenschrift
|
April 26, 2023
[Lipids-Diagnosis and therapy in diabetes mellitus (Update 2023)]
Thomas C Wascher, Bernhard Paulweber, Hermann Toplak, et al.
Wiener Klinische Wochenschrift
|
April 14, 2019
[Lipids-Diagnosis and therapy in diabetes mellitus (Update 2019)]
Thomas C Wascher, Bernhard Paulweber, Hermann Toplak, et al.
Wiener Klinische Wochenschrift
|
December 20, 2012
[Insulin therapy of diabetes]
Monika Lechleitner, Michael Roden, Raimund Weitgasser, et al.
Wiener Klinische Wochenschrift
|
April 26, 2023
[Obesity and type 2 diabetes (Update 2023)]
Martin Clodi, Hermann Toplak, Michael Resl, et al.
Wiener Klinische Wochenschrift
|
April 8, 2016
[Insulin therapy of diabetes]
Monika Lechleitner, Michael Roden, Raimund Weitgasser, et al.
Breast Cancer Research and Treatment
|
September 21, 2004
Genetic variants of the sulfotransferase 1A1 and breast cancer risk
Uwe Langsenlehner, Peter Krippl, Wilfried Renner, et al.
Angiology
|
July 24, 2009
The functional promoter polymorphism of the coagulation factor XII gene is not associated with peripheral arterial disease
Babak Yazdani-Biuki, Peter Krippl, Kerstin Brickmann, et al.
Breast Cancer Research and Treatment
|
July 20, 2007
Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study
Uwe Langsenlehner, Gerald Wolf, Tanja Langsenlehner, et al.
Page
of 8